“I have just checked my immigration status for both NIW and EB1A, and I-140 is approved for both of them. Thank you very much for everything. I am truly grateful for the experience of working with you.”

Case Summary:      

We are proud to share the success story of a distinguished biotechnology researcher whose specialized expertise lies in microbiological biotechnology and the diagnosis of pathogenic mycobacteria. This client secured approvals for both an EB-2 NIW (National Interest Waiver) and an EB1A (Extraordinary Ability) petition, reflecting the outstanding caliber of her research and the profound national importance of her work. The NIW petition, filed on April 24, 2024, was approved on February 8, 2025, and shortly after, her EB1A petition, filed on January 28, 2025, was approved on February 11, 2025.

Advancing Microbiological Biotechnology and Public Health
This researcher is widely recognized for pioneering contributions to microbiological biotechnology, particularly in developing diagnostic tools for pathogenic mycobacteria. She is especially well-known for creating a novel ELISA technique for strain-specific detection, a breakthrough with wide applications in veterinary medicine, food safety, and public health. Her research addresses urgent global challenges in the dairy industry and broader efforts to combat infectious disease.

Her work has been supported by prestigious institutions, including the Italian Ministry of Health, further underscoring its scientific and societal value. She has also been invited to present at leading international conferences, reflecting her recognition as a respected authority in the field.

Scholarly Impact and Peer Recognition
The client has documented her findings in 8 peer-reviewed journal articles (5 first-authored) and 2 abstracts, which have been cited 374 times by researchers across 47 countries. This broad international uptake demonstrates the far-reaching influence of her work.

She has also carried out at least 30 peer reviews for respected journals, further highlighting her authority in the field and the trust placed in her expertise by the scientific community. The high quality of her research has earned her invitations to serve as a speaker at renowned conferences and to collaborate across borders, enhancing the global impact of her discoveries.

Testimonial Support
 As one recommender emphasized:

 “Ultimately, [client] is conducting cutting-edge research into microbiological biotechnology and the molecular and immunological diagnosis of pathogenic mycobacteria. The high quality of her research is clearly shown by her extensive publication record in some of the most significant biotechnology journals in the world. Therefore, [client]’s research in the biotechnologies field is undoubtedly of benefit to both the U.S. and global research communities.”

NAILG’s Role and Case Outcome
 The North America Immigration Law Group (NAILG) played a central role in this dual success. By meticulously documenting the client’s academic credentials, scientific impact, and original contributions, NAILG demonstrated to USCIS that her expertise is indispensable to advancing U.S. interests in public health, food safety, and biomedical innovation. Through careful advocacy, NAILG framed her qualifications to show that she not only meets but exceeds the rigorous standards of both NIW and EB1A classifications. USCIS granted both petitions, affirming her status as a leading figure whose ongoing work will strengthen America’s scientific and healthcare leadership.